{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:57:55Z","timestamp":1783598275689,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11060-019-03145-8","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T06:11:58Z","timestamp":1552111918000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy"],"prefix":"10.1007","volume":"143","author":[{"given":"Andrew","family":"Deweyert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Iredale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-4314","authenticated-orcid":false,"given":"Matthew O.","family":"Hebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,9]]},"reference":[{"key":"3145_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Zhang J, Baker SJ, St. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251\u2013253","journal-title":"Nat Genet"},{"issue":"1","key":"3145_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/1570159X14666160509123229","volume":"15","author":"TB Johung","year":"2017","unstructured":"Johung TB, Monje M (2017) Diffuse intrinsic pontine glioma: new pathophysiological insights and emerging therapeutic targets. Curr Neuropharmacol 15(1):88\u201397","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"3145_CR3","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00381-017-3659-8","volume":"34","author":"S Harward","year":"2018","unstructured":"Harward S, Harrison Farber S, Malinzak M, Becher O, Thompson EM (2018) T2-weighted images are superior to other MR image types for the determination of diffuse intrinsic pontine glioma intratumoral heterogeneity. Childs Nerv Syst 34(3):449\u2013455","journal-title":"Childs Nerv Syst"},{"issue":"8","key":"3145_CR4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/neuonc\/nox021","volume":"19","author":"KJ Cohen","year":"2017","unstructured":"Cohen KJ, Jabado N, Grill J (2017) Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro oncology 19(8):1025\u20131034","journal-title":"Neuro oncology"},{"key":"3145_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2017.00495","volume":"8","author":"W Long","year":"2017","unstructured":"Long W, Yi Y, Chen S, Cao Q, Zhao W, Liu Q (2017) Potential new therapies for pediatric diffuse intrinsic pontine glioma. Front Pharmacol 8:1\u201313","journal-title":"Front Pharmacol"},{"key":"3145_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.critrevonc.2017.10.013","volume":"120","author":"HS Gwak","year":"2017","unstructured":"Gwak HS, Park HJ (2017) Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG). Crit Rev Oncol Hematol 120:111\u2013119","journal-title":"Crit Rev Oncol Hematol"},{"key":"3145_CR7","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.ejca.2012.04.011","volume":"48","author":"R Stupp","year":"2012","unstructured":"Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbal\u00fd V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH (2012) NovoTTF-100A versus physician\u2019s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 48:2192\u20132202","journal-title":"Eur J Cancer"},{"key":"3145_CR8","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1586\/ern.12.80","volume":"12","author":"E Fonkem","year":"2012","unstructured":"Fonkem E, Wong ET (2012) NovoTTF-100A: a new treatment modality for recurrent glioblastoma. Expert Rev Neurother 12:895\u2013899","journal-title":"Expert Rev Neurother"},{"key":"3145_CR9","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran D, Brem S, Hottinger A, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim CY, Paek SH, Nicholas G, Bruna J, Hirte H, Weller M, Palti Y, Hegi ME, Ram Z (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318:2306\u20132316","journal-title":"JAMA"},{"key":"3145_CR10","first-page":"71","volume":"36","author":"H Xu","year":"2016","unstructured":"Xu H, Bihari F, Whitehead S, Wong E, Schmid S, Hebb MO (2016) In vitro validation of intratumoral modulation therapy for glioblastoma. Anticancer Res 36:71\u201380","journal-title":"Anticancer Res"},{"key":"3145_CR11","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.1038\/s41598-018-25639-7","volume":"8","author":"AR Sebastiano Di","year":"2018","unstructured":"Di Sebastiano AR, Deweyert A, Benoit S, Iredale E, Xu H, De Oliveira C, Wong E, Schmid S, Hebb MO (2018) Preclinical outcomes of intratumoral modulation therapy for glioblastoma. Sci Rep 8:7301","journal-title":"Sci Rep"},{"key":"3145_CR12","first-page":"e55360","volume":"121","author":"GL Lin","year":"2017","unstructured":"Lin GL, Monje M (2017) A protocol for rapid post-mortem cell culture of diffuse intrinsic pontine glioma (DIPG). J Vis Exp 121:e55360","journal-title":"J Vis Exp"},{"issue":"7673","key":"3145_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","volume":"549","author":"HS Venkatesh","year":"2017","unstructured":"Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM, Ni J, Duveau DY, Morris PJ, Zhao JJ, Thomas CJ, Monje M (2017) Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature 549(7673):533\u2013537","journal-title":"Nature"},{"issue":"5","key":"3145_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.cell.2017.07.016","volume":"170","author":"EY Qin","year":"2017","unstructured":"Qin EY, Cooper DD, Abbott KL, Lennon J, Nagaraja S, Mackay A, Jones C, Vogel H, Jackson PK, Monje M (2017) Neural precursor-derived pleiotrophin mediates subventricular zone invasion by glioma. Cell 170(5):845\u2013859","journal-title":"Cell"},{"key":"3145_CR15","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","volume":"10","author":"S Ostermann","year":"2004","unstructured":"Ostermann S, Csajka C, Buclin T, Leyvraz S, Lejeune F, Decosterd LA, Stupp R (2004) Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 10:3728\u20133736","journal-title":"Clin Cancer Res"},{"key":"3145_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-7-1","volume":"7","author":"K Buch","year":"2012","unstructured":"Buch K, Peters T, Nawroth T, S\u00e4nger M, Schmidberger H, Langguth P (2012) Determination of cell survival after irradiation via clonogenic assay versus multiple MTT assay\u2014a comparative study. Radiat Oncol 7:1","journal-title":"Radiat Oncol"},{"key":"3145_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1667\/RR4633.1","volume":"189","author":"LM Smyth","year":"2018","unstructured":"Smyth LM, Rogers PAW, Crosbie JC, Donoghue JF (2018) Characterization of diffuse intrinsic pontine glioma radiosensitivity using synchrotron microbeam radiotherapy and conventional radiation therapy in vitro. Radiat Res 189:146\u2013155","journal-title":"Radiat Res"},{"key":"3145_CR18","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","volume":"64","author":"ED Kirson","year":"2004","unstructured":"Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzhaki A, Wasserman Y, Schatzberger R, Palti Y (2004) Disruption of cancer cell replication by alternating electric fields. Cancer Res 64:3288\u20133295","journal-title":"Cancer Res"},{"key":"3145_CR19","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1152\/jappl.1966.21.5.1619","volume":"21","author":"Y Palti","year":"1996","unstructured":"Palti Y (1996) Stimulation of internal organs by means of external applied electrodes. J Appl Physiol 21:1619\u20131623","journal-title":"J Appl Physiol"},{"key":"3145_CR20","first-page":"343","volume":"61","author":"FK Storm","year":"1982","unstructured":"Storm FK, Morton DL, Kaiser LR, Harrison WH, Elliott RS, Weisenburger TH, Parker RG, Haskell CM (1982) Clinical radiofrequency hyperthermia: a review. Natl Cancer Inst Monogr 61:343\u2013350","journal-title":"Natl Cancer Inst Monogr"},{"key":"3145_CR21","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.1088\/0031-9155\/60\/18\/7339","volume":"60","author":"C Wenger","year":"2015","unstructured":"Wenger C, Salvador R, Basser PJ, Miranda PC (2015) The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study. Phys Med Biol 60:7339\u20137357","journal-title":"Phys Med Biol"},{"key":"3145_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.ijrobp.2015.11.042","volume":"95","author":"C Wenger","year":"2016","unstructured":"Wenger C, Salvador R, Basser PJ, Miranda PC (2016) Improving tumor treating fields treatment efficacy in patients with glioblastoma using personalized array layouts. Int J Radiat Oncol Biol Phys 95:1137\u20131143","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3145_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0006-3495(93)81056-7","volume":"65","author":"P Paw\u0142owski","year":"1993","unstructured":"Paw\u0142owski P, Szutowicz I, Marsza\u0142ek P, Fikus M (1993) Bioelectrorheological model of the cell 5. Electrodestruction of cellular membrane in alternating electric field. Biophys J 65:541\u2013549","journal-title":"Biophys J"},{"key":"3145_CR24","doi-asserted-by":"publisher","first-page":"e0125269","DOI":"10.1371\/journal.pone.0125269","volume":"10","author":"N Gera","year":"2015","unstructured":"Gera N, Yang A, Holtzman TS, Lee SX, Wong ET, Swanson KD (2015) Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS ONE 10:e0125269","journal-title":"PLoS ONE"},{"key":"3145_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2018.6.JNS18854","volume":"21","author":"PF Morgenstern","year":"2018","unstructured":"Morgenstern PF, Zhou Z, Wembacher-Schr\u00f6der E, Cina V, Tsiouris AJ, Souweidane MM (2018) Clinical tolerance of corticospinal tracts in convection-enhanced delivery to the brainstem. J Neurosurg 21:1\u20137","journal-title":"J Neurosurg"},{"issue":"8","key":"3145_CR26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S1470-2045(18)30408-X","volume":"19","author":"DG Vuurden van","year":"2018","unstructured":"van Vuurden DG (2018) Convection-enhanced delivery: chemosurgery in diffuse intrinsic pontine glioma. Lancet Oncol 19(8):1001\u20131003","journal-title":"Lancet Oncol"},{"issue":"12","key":"3145_CR27","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/mds.115","volume":"33","author":"JGV Habets","year":"2018","unstructured":"Habets JGV, Heijmans M, Kuijf ML, Janssen MLF, Temel Y, Kubben PL (2018) An update on adaptive deep brain stimulation in Parkinson\u2019s disease. Mov Disord 33(12):1834\u20131843","journal-title":"Mov Disord"},{"issue":"3","key":"3145_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/jamaneurol.2017.4321","volume":"75","author":"A Ramirez-Zamora","year":"2018","unstructured":"Ramirez-Zamora A, Ostrem JL (2018) Globus pallidus interna or subthalamic nucleus deep brain stimulation for Parkinson disease: a review. JAMA Neurol 75(3):367\u2013372","journal-title":"JAMA Neurol"},{"key":"3145_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.08.015","author":"A Nowacki","year":"2018","unstructured":"Nowacki A, Galati S, Ai-Schlaeppi J, Bassetti C, Kaelin A, Pollo C (2018) Pedunculopontine nucleus: an integrative view with implications on deep brain stimulation. Neurobiol Dis. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2018.08.015","journal-title":"Neurobiol Dis"},{"key":"3145_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pneurobio.2015.08.001","volume":"133","author":"K Udupa","year":"2015","unstructured":"Udupa K, Chen R (2015) The mechanisms of action of deep brain stimulation and ideas for the future development. Prog Neurobiol 133:27\u201349","journal-title":"Prog Neurobiol"},{"key":"3145_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s13311-016-0426-6","volume":"12","author":"T Wichmann","year":"2016","unstructured":"Wichmann T, DeLong M (2016) Deep brain stimulation for movement disorders of basal ganglia origin: restoring function or functionality? Neurotherapeutics 12:264\u2013283","journal-title":"Neurotherapeutics"},{"key":"3145_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1152\/jn.00281.2015","volume":"115","author":"T Herrington","year":"2016","unstructured":"Herrington T, Cheng J, Eskandar E (2016) Mechanisms of deep brain stimulation. J Neurophysiol 115:19\u201338","journal-title":"J Neurophysiol"},{"key":"3145_CR33","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/neuonc\/now182","volume":"18","author":"AF Hottinger","year":"2016","unstructured":"Hottinger AF, Pacheco P, Stupp R (2016) Tumor treating fields: a novel treatment modality and its use in brain tumors. Neuro oncology 18:1338\u20131349","journal-title":"Neuro oncology"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-019-03145-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03145-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T00:11:47Z","timestamp":1583626307000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-019-03145-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,9]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3145"],"URL":"https:\/\/doi.org\/10.1007\/s11060-019-03145-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,9]]},"assertion":[{"value":"29 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Matthew O. Hebb and Susanne Schmid are inventors on the following patent applications that are assigned to \u201cLondon Health Sciences Centre Research Inc.\u201d (the applicant): PCT\/CA2016\/050556 entitled \u201cIntratumoral Modulation Therapy\u201d and corresponding national phase applications in Canada, United States, Europe and China. The authors have no other competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All human DIPG cells were obtained from Dr. Michelle Monje (Stanford University) in accordance with the ethical standards of the Institutional Review Board (IRB) at Stanford University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All human tissues were obtained with informed consent for research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}